Validation and Comparison of Psoriasis Case-Finding Algorithms Using International Classification of Diseases Nosology

Background The methodology of utilizing ICD nosology to identify psoriasis case cohorts within an EMR database has not been validated extensively. Objective To appraise the validity of the psoriasis case definition utilizing ICD-9 nosology and to compare performances of six distinct algorithms. Design Retrospective chart review of a randomly selected subset (n=966) of 2,737 cases with ≥1 ICD-9 diagnosis code for psoriasis in 2004–2013. Results Positive Predictive Values for the six algorithms ranged from 84.7% {Any Provider (AP) ≥ 1} to 97.7% {Dermatologist (Derm) ≥ 3}. Negative Predictive Values for the six algorithms evaluated ranged from 24.1% (‘Derm ≥ 3’) to 80.9% (‘Derm≥1’). NPV for ‘Derm≥1’ was 80.9%, while NPV for all other algorithms was ≤ 35.1%. Percent misclassification for the six algorithms ranged from 11.0% (‘Derm≥ 1’) to 46.3% (‘Derm≥ 3’). Increased frequency of code applied also resulted in corresponding significant increases in percent misclassification. Within class, percent misclassification for ‘Derm ≥ 1’ (11.0%) was significantly lower than for ‘AP≥ 1’ (15.3%, P<0.01). Conclusions At least one ICD-9 code applied by a dermatologist represents the strongest performing algorithm to identify psoriasis cases.

[1]  L. Herrinton,et al.  Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996–2009 , 2013, Pharmacoepidemiology and drug safety.

[2]  A. Armstrong,et al.  Clinical and Histologic Diagnostic Guidelines for Psoriasis: A Critical Review , 2013, Clinical Reviews in Allergy & Immunology.

[3]  A. Kimball,et al.  The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study , 2011, The British journal of dermatology.

[4]  T. Tsai,et al.  Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. , 2011, Journal of dermatological science.

[5]  S. Schneeweiss,et al.  Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. , 2011, JAMA.

[6]  Herng‐Ching Lin,et al.  Increased risk of acute myocardial infarction in patients with psoriasis: a 5-year population-based study in Taiwan. , 2011, Journal of the American Academy of Dermatology.

[7]  L. Naldi,et al.  Epidemiology of comorbidities in psoriasis , 2010, Dermatologic therapy.

[8]  Cynthia S Crowson,et al.  Potential misclassification of patients with psoriasis in electronic databases. , 2008, Journal of the American Academy of Dermatology.

[9]  A. Kimball,et al.  Cardiovascular Disease and Risk Factors among Psoriasis Patients in Two US Healthcare Databases, 2001–2002 , 2008, Dermatology.

[10]  S. Feldman,et al.  The comorbid state of psoriasis patients in a university dermatology practice , 2005, The Journal of dermatological treatment.

[11]  F. Granath,et al.  Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients , 2003, European Journal of Epidemiology.

[12]  D. Margolis,et al.  The risk of malignancy associated with psoriasis. , 2001, Archives of dermatology.

[13]  E. Christophers Psoriasis − epidemiology and clinical spectrum , 2001, Clinical and experimental dermatology.

[14]  Jashin J. Wu,et al.  Association of gender, tumor necrosis factor inhibitor therapy, and myocardial infarction risk in patients with psoriasis. , 2013, Journal of the American Academy of Dermatology.

[15]  J. Q. Rosso,et al.  Association of Psoriasis With Coronary Artery, Cerebrovascular, and Peripheral Vascular Diseases and Mortality , 2010 .

[16]  B. Gersh Risk of Myocardial Infarction in Patients With Psoriasis , 2007 .